Deciphering the molecular mechanism of FLT3 resistance mutations
Panagiota S. Georgoulia(Linnaeus University), Ran Friedman(Linnaeus University)
Cited by 26
Related Papers
BCR-ABL1 Compound Mutations Combining Key Kinase Domain Positions Confer Clinical Resistance to Ponatinib in Ph Chromosome-Positive Leukemia
|Cancer Cell|2014|366
Resistance to FLT3 inhibitors involves different molecular mechanisms and reduces new DNA synthesis
|Biochemistry and Biophysics Reports|2025|2